Whole genome sequencing of rare olfactory neuroblastoma
The Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have conducted whole genome sequencing (WGS) of a rare nasal tract cancer called olfactory neuroblastoma ...
Genetics
May 23, 2012 |
not rated yet |
0
|
Cancer patient gets new lease on life through clinical trial
Arizona resident Evelyn Sorensen is in a far different place today than she was six months ago, thanks to a cutting-edge cancer clinical trial being conducted at the Virginia G. Piper Cancer Center at Scottsdale Healthcare ...
Cancer
Apr 30, 2012 |
5 / 5 (2) |
0
BIND presents late-breaker clinical data at AACR on BIND-014's promising antitumor effects
BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted therapeutics called AccurinsTM, announced today the presentation of late-breaker clinical data for BIND-014, ...
Cancer
Apr 04, 2012 |
not rated yet |
0
Pancreatic cancer clinical trial results released
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute ...
Cancer
Apr 03, 2012 |
not rated yet |
0
Preliminary findings about whole-genome sequencing of triple-negative breast cancer presented
Because cases of Triple-Negative Breast Cancer (TNBC) are so genetically different, whole-genome sequencing is needed to detect the subtle molecular differences that might point to specific treatments for individual patients.
Cancer
Apr 02, 2012 |
not rated yet |
0
Study role testosterone may play in triple negative breast cancer
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. ...
Cancer
Mar 23, 2012 |
5 / 5 (1) |
0
|
Combination drug therapy urged to battle lung cancer
Combination drug therapy may be needed to combat non-small cell lung cancer (NSCLC), according to a study by the Translational Genomics Research Institute (TGen) and Van Andel Research Institute (VARI).
Cancer
Feb 02, 2012 |
not rated yet |
0
FDA approves new skin cancer drug
A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the U.S. Food and Drug Administration, a remarkable ...
Cancer
Feb 01, 2012 |
not rated yet |
0
'Seena' clinical trials named for pancreatic cancer advocate
A son's passion to find a cure for the cancer that claimed the life of his mother has led to a new series of clinical trials under a Translational Genomics Research Institute (TGen) initiative to find a cure for pancreatic ...
Cancer
Dec 01, 2011 |
not rated yet |
0
TGen, Virginia G. Piper Cancer Center studying new breast cancer drug
A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation ...
Cancer
Jul 20, 2011 |
not rated yet |
0
New study identifies compounds that could slow down Alzheimer's disease
A family of naturally occurring plant compounds could help prevent or delay memory loss associated with Alzheimer's disease, according to a new study by the Translational Genomics Research Institute (TGen).
Medical research
May 26, 2011 |
3 / 5 (1) |
0
|
- Pages: 1 2
